NSOEG is established under the Committee for Medicinal Products for Human Use (CHMP) and the Non-clinical Working Party (NcWP).
The group’s tasks include:
- Supporting the Non-clinical working party with answering queries about issues related to nitrosamine impurities
- Harmonising the establishment and assessment of the acceptable intake limit for nitrosamine impurities in the EU
- Liaising with international regulators to seek international harmonisation and facilitate regulatory convergence
Information on the group’s mandate, objectives and rules of procedure is available below: